# Michael Guger

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michael-guger/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,166 |
| Field | Multiple Sclerosis Research Studies |
| h-index | 17 |
| i10-index | 29 |
| Last Known Institution | Johannes Kepler University of Linz |
| OpenAlex ID | https://openalex.org/A5038774465 |
| ORCID iD | 0000-0001-8219-781X |
| Works | 76 |

## Researcher papers

- [Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)](https://scholariq.org/papers/multiple-sclerosis-therapy-consensus-group-mstcg-position-statement-on-disease/)
- [Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy](https://scholariq.org/papers/cerebrospinal-fluid-parameters-of-b-cell-related-activity-in-patients-with/)
- [High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria](https://scholariq.org/papers/high-efficacy-of-rituximab-for-myasthenia-gravis-a-comprehensive-nationwide/)
- [Caregiving and Caregiver Burden in Dementia Home Care: Results from the Prospective Dementia Registry (PRODEM) of the Austrian Alzheimer Society](https://scholariq.org/papers/caregiving-and-caregiver-burden-in-dementia-home-care-results-from-the/)
- [Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People](https://scholariq.org/papers/neuromyelitis-optica-in-austria-in-2011-to-bridge-the-gap-between/)
- [Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium](https://scholariq.org/papers/clinicogenomic-factors-of-biotherapy-immunogenicity-in-autoimmune-disease-a/)
- [Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development](https://scholariq.org/papers/early-detection-of-neutralizing-antibodies-to-interferon-beta-in-multiple/)
- [Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients](https://scholariq.org/papers/cytokine-profiles-show-heterogeneity-of-interferon-response-in-multiple/)
- [Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women](https://scholariq.org/papers/specific-serum-igg-igm-and-iga-antibodies-to-human-papillomavirus-types-6-11-16/)
- [COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry](https://scholariq.org/papers/covid-19-severity-and-mortality-in-multiple-sclerosis-are-not-associated-with/)
- [Caregiver burden in patients with behavioural variant frontotemporal dementia and non-fluent variant and semantic variant primary progressive aphasia](https://scholariq.org/papers/caregiver-burden-in-patients-with-behavioural-variant-frontotemporal-dementia/)

## Researcher topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)
- [Polyomavirus and related diseases](https://scholariq.org/topics/polyomavirus-and-related-diseases/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Researcher university

- [Johannes Kepler University of Linz](https://scholariq.org/institutions/johannes-kepler-university-of-linz/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.